Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Cell-targeted Biophotonic Nanoparticles for Vision Restoration

Project description

Nano-enabled technology for damaged retinal-network restoration

Retinitis pigmentosa (RP) and age-related macular degeneration (AMD) are marked by severe retinal degeneration and loss of high-resolution vision. Current retinal prostheses have low resolution and indiscriminately activate the inner retina. Moreover, strategies targeting ON-bipolar cells (BCs) face challenges in efficacy and clinical readiness. The EU-funded NanoFlash project aims to develop nano-enabled technology to restore damaged retinal networks and treat RP and AMD. The project will create nanoparticles that target specific retinal receptors, optimising their design for effective stimulation. These particles will be tested in models to evaluate their potential for visual restoration, advancing therapies for currently incurable retinal diseases in the EU.

Objective

NanoFlash aims to develop disruptive nano-enabled technology to restore damaged neuronal networks through precise stimulation of specific retinal cells. Focusing on non-genetic reactivation of physiological vision, NanoFlash targets treatment of retinitis pigments (RP) and age-related macular degeneration (AMD), both marked by severe retinal degradation and loss of high-resolution vision. Current retinal prostheses suffer from low resolution and indiscriminate activation of inner retina, while ontogenetic strategies targeting ON-bipolar cells (BCs) face significant limitation in efficacy and translational readiness.
Circumventing these challenges, NanoFlash will engineer photovoltaic polymer nanoparticles (NPs) functionalist to target mGluR6 receptors, a unigue hallmark on PN-BCs. Using state-of-the-art modelling and bioelectronic in vitro platforms, the project will drive the rational design and optimisation of NPs, tailoring their size, architecture, spectral sensitivity, and transduction efficiency. Advanced organ-on-chip devices will be developed to screen and validate NP targeting and retinal reactivation performance in retinal organdies and explants. Lead NP candidates will then be tested in rod-cone degeneration rodent models, assessing targeting precision, suspension stability, and visual restoration outcomes.
NanoFlash represents a major leap forward in retinal prosthetics by restoring the ON/OFF pathway segregation critical for spatial resolution, contrast sensitivity, and motion detection. This highly interdisciplinary effort will push the frontiers of bio-organic optoelectronics and neurophysiology, providing essential preclinical data toward therapies for currently incurable retinal diseases, addressing a pressing unmet medical need in the EU.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-EIC - HORIZON EIC Grants

See all projects funded under this funding scheme

Call for proposal

(opens in new window) HORIZON-EIC-2025-PATHFINDEROPEN

See all projects funded under this call

Coordinator

THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE
Net EU contribution
€ 898 075,00
Address
TRINITY LANE THE OLD SCHOOLS
CB2 1TN CAMBRIDGE
United Kingdom
Region
East of England East Anglia Cambridgeshire CC
Activity type
Higher or Secondary Education Establishments
Links
Total cost
€ 898 075,00

Participants (3)